Mesenchymal stem cells (MSCs), multipotent stromal cells, have attracted extensive
attention in the field of regenerative medicine and cell therapy due to the capacity of self …

Mesenchymal stromal/stem cells (MSCs) are currently applied in regenerative medicine and
tissue engineering. Numerous clinical studies have indicated that MSCs from different tissue …

Mesenchymal stem/stromal cells (MSCs) have the ability to secrete bioactive molecules,
exerting multiple biological effects, such as tissue regeneration, reduction of inflammation …

Introduction: The secretome of mesenchymal stromal cells (MSCs) serves as an innovative
tool employed in the regenerative medicine approach. In this particular context, three …

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is
characterized by the degeneration of the dopamine (DA) neurons in the substantia nigra …

Background Umbilical cord blood (UCB) is a clinically relevant alternative source of
hematopoietic stem/progenitor cells (HSPC). To overcome the low cell number per UCB unit …

Human mesenchymal stem cells (hMSCs) are manufactured as cell therapy products. This
requires a tightly controlled and fully understood production process, usually taking place in …

Mesenchymal stem cells (MSCs) have a great regenerative and immunomodulatory
potential that was successfully tested in numerous pre-clinical and clinical studies of various …

Cleft lip and palate (CL/P) is the most prevalent craniofacial birth defect in humans. None of
the surgical procedures currently used for CL/P repair lead to definitive correction of hard …

Mesenchymal stromal cells (MSC) have been investigated for their remarkable regenerative
and immunomodulatory therapeutic potential. However, clinical trials have revealed limited …